You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.


Go back


Active ingredients of Relvar Ellipta 12

Relvar Ellipta (fluticasone furoate/vilanterol [as trifenatate]) inhalation powder

Each single inhalation of fluticasone furoate (FF) 100 micrograms (mcg) and vilanterol (VI) 25 mcg provides a delivered dose of 92 mcg FF and 22 mcg VI.

Each single inhalation of FF 200 mcg and VI 25 mcg provides a delivered dose of 184 mcg of FF and 22 mcg of VI.


RELVAR Ellipta was developed in collaboration with INNOVIVA Inc.

Relvar and Ellipta are registered trademarks of the GlaxoSmithKline Group of Companies